Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ADX:JULPHAR'
s Current Ratio Range Over the Past 10 Years
Min: 0.87 Med: 2.25 Max: 3.25
Current: 2.86
During the past 13 years, Gulf Pharmaceutical Industries PSC's highest Current Ratio was 3.25. The lowest was 0.87. And the median was 2.25.
ADX:JULPHAR's Current Ratio is ranked better than 86.67% of 120
companies
in the Medical Distribution industry
Industry Median: 1.395
vs ADX:JULPHAR: 2.86
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Gulf Pharmaceutical Industries PSC Current Ratio Related Terms
Gulf Pharmaceutical Industries PSC Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Pharmaceutical Industries PSC Current Ratio Chart
ADX:JULPHAR vs MCK, CAH, COR: Current Ratio Comparison
For the Medical Distribution subindustry, Gulf Pharmaceutical Industries PSC's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gulf Pharmaceutical Industries PSC Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Current Ratio distribution charts can be found below:
* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) has a Current Ratio of 2.86 as of Mar. 2026. This is 27% above median its historical median of 2.25. Over the past decade, Gulf Pharmaceutical Industries PSC's Current Ratio has ranged from 0.87 to 3.25. According to the industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #16 out of 120 companies in the Medical Distribution industry, placing it in the top 13.3%.
Is Gulf Pharmaceutical Industries PSC's Current Ratio too high?
Gulf Pharmaceutical Industries PSC's current Current Ratio of 2.86 is 27% above median its 10-year median of 2.25. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 3.25. The Medical Distribution industry median Current Ratio is 1.40. Gulf Pharmaceutical Industries PSC's value of 2.86 is 105% above this industry median. Based on the distribution chart, Gulf Pharmaceutical Industries PSC ranks #16 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Gulf Pharmaceutical Industries PSC has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gulf Pharmaceutical Industries PSC's Current Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #16 out of 120 companies for Current Ratio. This places Gulf Pharmaceutical Industries PSC in the top 13% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.40. Gulf Pharmaceutical Industries PSC's value of 2.86 is 105% above this benchmark. Historically, Gulf Pharmaceutical Industries PSC's own Current Ratio has ranged from 0.87 to 3.25 over the past decade. While the company's 10-year median is 2.25 vs. the industry median of 1.40, Gulf Pharmaceutical Industries PSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.40, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gulf Pharmaceutical Industries PSC's current Current Ratio of 2.86 is 105% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gulf Pharmaceutical Industries PSC's current Current Ratio is 2.86, which is 27% above median its own 10-year median of 2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Pharmaceutical Industries PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) is currently considered Fairly Valued. The stock's GF Value™ is د.إ1.09, compared to a current price of د.إ1.04 — trading 4.6% below its estimated fair value. The current Current Ratio is 2.86, which is 27% above median its 10-year median of 2.25 and 105% above the Medical Distribution industry median of 1.40. Gulf Pharmaceutical Industries PSC's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Gulf Pharmaceutical Industries PSC (ADX:JULPHAR), the current Current Ratio is 2.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued.
The current stock price of د.إ1.04 is trading 4.6% below its estimated GF Value™ of د.إ1.09.
GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.
Key valuation signals for ADX:JULPHAR:
Current Ratio: 2.86 (27% above median its 10-year median of 2.25)
GF Value™: د.إ1.09 vs. price of د.إ1.04 (4.6% below fair value)
Industry Position: 105% above the Medical Distribution median (#16 of 120)
No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gulf Pharmaceutical Industries PSC Business Description
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
54GF Score
Get the complete analysis for ADX:JULPHAR
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:JULPHAR has been successfully added to your 
